NCT04703998 is a NA clinical trial of Arthroscopic rotator cuff repair in Rotator Cuff Tears, sponsored by Hospital Italiano de Buenos Aires.

Who is sponsoring NCT04703998?

NCT04703998 is sponsored by Hospital Italiano de Buenos Aires.

What drugs are being tested in NCT04703998?

Interventions in NCT04703998: Arthroscopic rotator cuff repair, platelet rich plasma.

What condition does NCT04703998 study?

NCT04703998 studies Rotator Cuff Tears.

Is NCT04703998 still recruiting?

NCT04703998 is currently completed. Last updated 22 December 2022.

Last reviewed 2022-12-22 · How we verify

NCT04703998

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Arthroscopic Rotator Cuff Repair Augmented With Platelet Rich Plasma

Completed NA Last updated 22 December 2022

What this trial tests

NA trial testing Arthroscopic rotator cuff repair in Rotator Cuff Tears in 103 participants. Completed in 1 September 2022.

Timeline

3 January 2021

Primary endpoint
1 September 2022

1 September 2022

Quick facts

Lead sponsor	Hospital Italiano de Buenos Aires
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	103
Start date	3 January 2021
Primary completion	1 September 2022
Estimated completion	1 September 2022
Sites	1 location across Argentina

Drugs / interventions tested

Arthroscopic rotator cuff repair
platelet rich plasma — full drug profile →

Conditions studied

Rotator Cuff Tears — all drugs for Rotator Cuff Tears →

Sponsor

Hospital Italiano de Buenos Aires

Who can join

Adults 50 to 75, any sex, with Rotator Cuff Tears. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Purpose: To assess whether the use of platelet-rich plasma used as an adjuvant to arthroscopic rotator cuff repairs modify the rate of re-tears (measured by MRI) compared to a control group that only underwent the isolated arthroscopic repair. Hypothesis: Platelet rich plasma used as an adjuvant to arthroscopic rotator cuff repairs decrease the rate of retears.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Leukocyte-Poor Platelet-Rich Plasma as an Adjuvant to Arthroscopic Rotator Cuff Repair Reduces the Retear Rate But Does Not Improve Functional Outcomes: A Double-Blind Randomized Controlled Trial.
Rossi LA, Gorodischer TD, Camino P, Brandariz RN, et al · · 2024 · cited 12× · PMID 38587033 · DOI 10.1177/03635465241239062

Verify or expand the search:

Other trials of Arthroscopic rotator cuff repair

Trials testing the same drug.

NCT07311616 — A Study on the Effectiveness of Preventive Extensive Release of the Rotator Interval and Joint Capsule to Reduce Postope · NA · not yet recruiting
NCT06145815 — Machine Learning Predictive Model for Rotator Cuff Repair Failure · completed
NCT05477771 — The Cross-sectional Area of the Long Head of the Biceps Tendon and the Rotator Cuff Tear Position · NA · unknown
NCT04450342 — REGENETEN™ Bioinductive Implant System in Full-thickness Tears · NA · terminated
NCT06120998 — Quality of Life After Arthroscopic Rotator Cuff Repair · completed

Other recruiting trials for Rotator Cuff Tears

Currently open trials in the same condition.

NCT07383038 — Effect of Mobilization With Movement in Patients With Rotator Cuff Lesions · NA · recruiting
NCT06918041 — FiberLocker® System Augmentation of Rotator Cuff Repairs · NA · recruiting
NCT06886932 — Pain Education After Rotator Cuff Surgery · recruiting
NCT07001566 — The Impact of Cervical Radiculopathy on Functionality in Patients Undergoing Rotator Cuff Repair · recruiting
NCT06733480 — Innovating Physical Therapy: A Pilot Study on Band Connect's Impact on Compliance, Satisfaction, and Revenue · NA · recruiting

Other Hospital Italiano de Buenos Aires trials

Trials by the same sponsor.

NCT07397416 — Impact of Implementing a Rapid PCR-based Algorithm for Carbapenemase-producing Enterobacterales (CPE) and Infection Cont · NA · not yet recruiting
NCT07167173 — Predictive Model for Multidrug Resistance in Patients Admitted to the Emergency Department With Sepsis · not yet recruiting
NCT06683781 — Ventilatory Settings and Monitoring Variables Associated With Weaning Failure in Critically Ill Patients · recruiting
NCT06573723 — Institutional Registry of Rare Diseases · recruiting
NCT06609798 — Ultrasound Assessment During Weaning from Mechanical Ventilation · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04703998 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospital Italiano de Buenos Aires
Last refreshed: 22 December 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04703998.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing